NCT06116981

Brief Summary

High Induction Magnetic Field Therapy is a therapeutic method that uses high-intensity fields (up to 2.5 T) that produce high current density in exposed tissue. While there are studies in the literature on devices with 2.5 T, there is no research on the effect of 4 T. Magnetic field application contributes significantly to the healing process. It is an easier, cheaper, and more comfortable application. The magnetic field has been clinically proven to be safe. It is a practical, non-invasive method to induce cell and tissue modifications, correcting selected pathological conditions through magnetic application. The aim of the study is to investigate whether High Induction Magnetic Field therapy applied in addition to conservative treatment in patients with shoulder pain makes a difference compared to conservative treatment alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

October 14, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 3, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2024

Completed
Last Updated

January 5, 2024

Status Verified

October 1, 2023

Enrollment Period

3 months

First QC Date

October 14, 2023

Last Update Submit

January 3, 2024

Conditions

Keywords

Magnetic Field TherapyShoulder PainRange of Motion

Outcome Measures

Primary Outcomes (4)

  • Visual analogue scale-VAS

    A score between 0 and 10 points is given and used to evaluate pain.

    baseline and after 4 weeks of treatment

  • Range of Motion

    Range of Motion of Shoulder Joint: Shoulder joint flexion (0-180 degrees), abduction (0-180 degrees), external rotation (0-90 degrees) and internal rotation (0-90 degrees) range of motion will be measured with a goniometer. Higher values indicate increased mobility.

    baseline and after 4 weeks of treatment

  • Disabilities of the Arm, Shoulder and Hand (DASH)

    The DASH is a 30-item patient-reported outcome measure utilized to assess symptoms and function of the entire upper extremity. Total scores range from 0 (minimum) to (100) maximum. The first 30 questions of the survey will be applied. As the score increases, the disability level increases.

    baseline and after 4 weeks of treatment

  • Constant Murley Score

    It is a 100-point scale consisting of 15 points for pain, 20 points for daily activities, 40 points for pain-free joint range of motion, and 25 points for strength parameters. While pain and daily living activities are evaluated by the patient, joint range of motion and strength are evaluated by the clinician. A higher score corresponds to a higher-quality of function.

    baseline and after 4 weeks of treatment

Study Arms (2)

Experimental Group

EXPERIMENTAL

The experimental group consists of individuals who received high-induction magnetic field therapy in addition to conservative treatment (routine rehabilitation sessions including stretching, transcutaneous electrical nerve stimulation, and exercises.).

Other: High Induction Magnetic Field TherapyOther: Conservative Treatment

Comparison Group

ACTIVE COMPARATOR

Conservative Treatment Group: Group with routine rehabilitation sessions including stretching, transcutaneous electrical nerve stimulation, and exercises.

Other: Conservative Treatment

Interventions

High Induction Magnetic Field Therapy is a method that has no side effects, is non-invasive and easy to apply, and is used to increase circulation in tissues.

Experimental Group

Shoulder exercises, transcutaneous electrical nerve stimulation, stretching.

Comparison GroupExperimental Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntarily agreeing to participate in the research.
  • Being between the ages of 18 and 65
  • Having at least one of the following diagnoses: shoulder impingement syndrome, rotator cuff rupture, and subacromial bursitis.
  • Having the cognitive fitness to perform the surveys and tests to be used during the research.

You may not qualify if:

  • Having a chronic disease such as neurological, orthopedic or cardiovascular that cannot be controlled with medication.
  • Not volunteering to participate in the research.
  • Pregnant and suspected pregnancy individuals
  • Individuals with pacemakers
  • Individuals with implantable ear hearing aids
  • Individuals with metallic implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KTO Karatay University

Konya, Karatay, 42030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Shoulder Pain

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Özlem Akkoyun Sert, PhD

    KTO Karatay University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group 1: Conservative Treatment Group Grou 2: Conservative Treatment + High Induction Magnetic Field Therapy
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2023

First Posted

November 3, 2023

Study Start

October 1, 2023

Primary Completion

January 1, 2024

Study Completion

January 2, 2024

Last Updated

January 5, 2024

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations